Abstract:Cancer immunotherapies, including immune checkpoint inhibition (ICI) and adoptive immune cells therapy, are promising therapeutic strategies. They reactivate the function of immune cells and induce immune responses to attack tumor cells. Although these novel therapies benefited a large amount of cancer patients, many cancer patients have shown fair responses even resistance to cancer immunotherapies, limiting their wide clinical application. Therefore, it is urgent to explore the underlying mechanisms of low response and resistance of cancer immunotherapy to enhance their treatment efficacy. The programmed cell death (PCD) including the ferroptosis, has been demonstrated to play essential roles in antitumor immunity and in regulating the immune response to ICIs. Ferroptosis, a phospholipid peroxidation-mediated, iron-dependent membrane damage, exhibite three critical hallmarks: the oxidation of phospholipids, the lack of lipid peroxide repair capability and the overloading of redox-active iron. Notably, ferroptosis was found to plays important roles in regulating tumor immunity and response to immunotherapy. Therefore, targeting ferroptosis alone or in combination with immunotherapy may provide novel options to promote their antitumor efficacy. However, the effect of ferroptosis on tumor immunity and immunotherapy is affected by the interaction of ferroptosis and cancer cells, immune cells, tumor microenvironment (TME) and others. In this review, we summarized and discussed the critical roles of ferroptosis in regulating antitumor immunity, TME and in the improvement of the therapeutic efficacy of immunotherapy in cancers.

Ferroptosis and Its Interaction with Tumor Immune Microenvironment in Liver Cancer.

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects

Immunomodulation of cuproptosis and ferroptosis in liver cancer

Iron Metabolism, Ferroptosis, and Lncrna in Cancer: Knowns and Unknowns

Ferroptosis: a New Promising Target for Hepatocellular Carcinoma Therapy

Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors

Ferroptosis: insight into the treatment of hepatocellular carcinoma

Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Ferroptosis: a new hunter of hepatocellular carcinoma

A Promising Future of Ferroptosis in Tumor Therapy

Current Progress of Ferroptosis Study in Hepatocellular Carcinoma

Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy

Ferroptosis in cancer and cancer immunotherapy

Ferroptosis: a double-edged sword mediating immune tolerance of cancer

Ferroptosis as a potential target for cancer therapy

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

The new era of lung cancer therapy: Combining immunotherapy with ferroptosis

Ferroptosis and its emerging role in tumor

Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds